3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
12
Fallopian Tube Neoplasms
8
Sarcoma
2
Neoplasms
2
Neoplasm Metastasis
2
Multi-centric Castleman's Disease
2
Breast Neoplasms
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Sarcoma, Ewing
1
Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma
1
Recurrent Epithelial Ovarian, Fallopian or Peritoneal Carcinoma
1
Peritoneal Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Ovarian Cancer Recurrent
1
Macular dystrophy, corneal type 1
1
Lymphoproliferative Disorders
1
Lymphadenopathy
1
Liposarcoma
1
Leiomyosarcoma
1
Hodgkin Disease
1
Histiocytoma, Malignant Fibrous
1
HIV Infections
1
Gliosarcoma
1
Glioblastoma
1
Fallopian Tube Mucinous Adenocarcinoma
1
Endometrial Neoplasms
1
Interventions
Rituximab
23
Cyclophosphamide
21
Prednisone
16
Doxorubicin
14
Magnetic Resonance Spectroscopy
13
Vincristine
11
Specimen Handling
11
Lenalidomide
10
ibrutinib
8
Biopsy
8
obinutuzumab
7
polatuzumab vedotin
6
glofitamab
6
Gemcitabine
6
Oxaliplatin
5
venetoclax
4
prednylidene
4
pembrolizumab
4
fludarabine
4
deltacortene
4
Prednisolone
4
Etoposide
4
Dexamethasone
4
Cyclosporine
4
CT-P10
4
fludarabine phosphate
3
Whole-Body Irradiation
3
R-CHOP protocol
3
Nivolumab
3
Mycophenolic Acid
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Large B-Cell, Diffuse
×
liposomal doxorubicin
×
30 days
×
Clear all
No trials found.